Soluble CD40 Levels in Plasma Are Associated with Cardiovascular Disease and in Carotid Plaques with a Vulnerable Phenotype

Atheroprotective roles of smooth muscle cell phenotypic modulation and the TCF21 disease gene as revealed by single-cell analysis

(2019) Robert C. Wirka et al.   NATURE MEDICINE

Association of soluble CD40L with short-term and long-term cardiovascular and all-cause mortality: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study

(2019) Ingrid Gergei et al.   ATHEROSCLEROSIS

Association between CD40 polymorphisms and systemic lupus erythematosus and correlation between soluble CD40 and CD40 ligand levels in the disease: a meta-analysis

(2019) S -C Bae et al.   LUPUS

Single-cell immune landscape of human atherosclerotic plaques

(2019) Dawn M. Fernandez et al.   NATURE MEDICINE

CD40 as a therapeutic target in Sjögren’s syndrome

(2018) Kerry Jobling et al.   Expert Review of Clinical Immunology

Targeting CD40-Induced TRAF6 Signaling in Macrophages Reduces Atherosclerosis

(2018) Tom T.P. Seijkens et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The relationship between soluble CD40 ligand level and atherosclerosis in white-coat hypertension

(2017) Yu-qing Huang et al.   JOURNAL OF HUMAN HYPERTENSION

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

(2017) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Measures of atherosclerotic burden are associated with clinically manifest cardiovascular disease in type 2 diabetes: a European cross-sectional study

(2015) A. C. Shore et al.   JOURNAL OF INTERNAL MEDICINE

Inflammation and plaque vulnerability

(2015) G. K. Hansson et al.   JOURNAL OF INTERNAL MEDICINE

Treatment with beta-blockers is associated with lower levels of Lp-PLA2 and suPAR in carotid plaques

(2013) Giuseppe Asciutto et al.   CARDIOVASCULAR PATHOLOGY

Pathophysiology of Atherosclerosis Plaque Progression

(2013) Kenichi Sakakura et al.   Heart Lung and Circulation

Increased circulating soluble CD40 levels in patients with slow coronary flow phenomenon: an observational study

(2012) Murtaza Emre Durakoglugil et al.   Anadolu Kardiyoloji Dergisi-The Anatolian Journal of Cardiology

Upregulation of CD40 ligand and enhanced monocyte-platelet aggregate formation are associated with worse clinical outcome after ischaemic stroke

(2012) Grzegorz Dworacki et al.   THROMBOSIS AND HAEMOSTASIS

Levels of sCD40 Ligand in Chronic and Acute Coronary Syndromes and its Relation to Angiographic Extent of Coronary Arterial Narrowing

(2010) Hanan H. Fouad et al.   ANGIOLOGY

Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile

(2010) Esther Lutgens et al.   JOURNAL OF EXPERIMENTAL MEDICINE